1H, 15N and 13C sequence specific backbone assignment of the vanadate inhibited hematopoietic tyrosine phosphatase

[1]  W. Peti,et al.  The KIM-family protein-tyrosine phosphatases use distinct reversible oxidation intermediates: Intramolecular or intermolecular disulfide bond formation , 2017, The Journal of Biological Chemistry.

[2]  K. Lindorff-Larsen,et al.  Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery. , 2017, Molecular cell.

[3]  T. Mustelin,et al.  Inhibition of Hematopoietic Protein Tyrosine Phosphatase Augments and Prolongs ERK1/2 and p38 Activation , 2012, ACS chemical biology.

[4]  Gerhard Hummer,et al.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase. , 2011, Nature chemical biology.

[5]  A. Barr,et al.  Sequence-specific 1H, 13C and 15N backbone resonance assignments of the 34 kDa catalytic domain of human PTPN7 , 2008, Biomolecular NMR assignments.

[6]  Rebecca Page,et al.  Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost. , 2007, Protein expression and purification.

[7]  Wayne Boucher,et al.  The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.

[8]  R. Pulido,et al.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. , 2003, The Biochemical journal.

[9]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[10]  H. Griesser,et al.  A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. , 1994, Leukemia.

[11]  M. Minden,et al.  Cloning and expression of an inducible lymphoid‐specific, protein tyrosine phosphatase (HePTPase) , 1992, European journal of immunology.